Literature DB >> 25776761

IFI44 suppresses HIV-1 LTR promoter activity and facilitates its latency.

Derek Power1, Netty Santoso2, Michael Dieringer3, Jack Yu3, Huachao Huang1, Sydney Simpson1, Ishir Seth1, Hongyu Miao4, Jian Zhu5.   

Abstract

IFI44 is an interferon-alfa inducible protein, and is associated with infection of several viruses. However, IFI44 elicits minimal antiviral effects on these viruses, and its exact role is still unknown. Here we show that IFI44 inhibits HIV-1 replication in vitro. Through depletion of endogenous IFI44 or overexpression of IFI44 we confirm that IFI44 suppresses HIV-1 LTR promoter activity and affects viral transcription. Furthermore, we find that IFI44 localizes to nuclei and binds to the HIV-1 LTR promoter in HIV-1 infected cells. Removing suppression of HIV-1 transcription benefits reactivation of HIV-1 proviruses for purging latent reservoirs. We demonstrate that depletion of endogenous IFI44 in J-LAT cells induces reactivation of latent HIV-1. Based on these results, we propose a model in which IFI44 is recruited to the HIV-1 LTR, which may suppress viral transcription and prevent reactivation of latent HIV-1. Our study suggests a previously unrecognized anti-HIV phenomenon for interferon-stimulated proteins.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV-1; IFI44; ISG; Interferon; LTR; Latency; Reactivation; Transcription

Mesh:

Substances:

Year:  2015        PMID: 25776761      PMCID: PMC4437885          DOI: 10.1016/j.virol.2015.02.046

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  49 in total

1.  Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.

Authors:  Xianghui Yu; Yunkai Yu; Bindong Liu; Kun Luo; Wei Kong; Panyong Mao; Xiao-Fang Yu
Journal:  Science       Date:  2003-10-16       Impact factor: 47.728

2.  Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter.

Authors:  Marina Lusic; Alessandro Marcello; Anna Cereseto; Mauro Giacca
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

3.  Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo.

Authors:  Satish K Pillai; Mohamed Abdel-Mohsen; John Guatelli; Mark Skasko; Alexander Monto; Katsuya Fujimoto; Steven Yukl; Warner C Greene; Helen Kovari; Andri Rauch; Jacques Fellay; Manuel Battegay; Bernard Hirschel; Andrea Witteck; Enos Bernasconi; Bruno Ledergerber; Huldrych F Günthard; Joseph K Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

4.  Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma.

Authors:  Y A Bochkov; K M Hanson; S Keles; R A Brockman-Schneider; N N Jarjour; J E Gern
Journal:  Mucosal Immunol       Date:  2009-08-26       Impact factor: 7.313

Review 5.  The restriction factors of human immunodeficiency virus.

Authors:  Reuben S Harris; Judd F Hultquist; David T Evans
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

6.  TNPO3 is required for HIV-1 replication after nuclear import but prior to integration and binds the HIV-1 core.

Authors:  Jose Carlos Valle-Casuso; Francesca Di Nunzio; Yang Yang; Natalia Reszka; Maritza Lienlaf; Nathalie Arhel; Patricio Perez; Abraham L Brass; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

7.  Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection.

Authors:  V Vieillard; S Jouveshomme; N Leflour; E Jean-Pierre; P Debre; E De Maeyer; B Autran
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

8.  Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells.

Authors:  B F Fernie; G Poli; A S Fauci
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

Review 9.  Human cellular restriction factors that target HIV-1 replication.

Authors:  Klaus Strebel; Jeremy Luban; Kuan-Teh Jeang
Journal:  BMC Med       Date:  2009-09-16       Impact factor: 8.775

10.  Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation.

Authors:  E Verdin; P Paras; C Van Lint
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

View more
  41 in total

1.  Screening of an FDA-approved compound library identifies levosimendan as a novel anti-HIV-1 agent that inhibits viral transcription.

Authors:  Tsuyoshi Hayashi; Maxime Jean; Huachao Huang; Sydney Simpson; Netty G Santoso; Jian Zhu
Journal:  Antiviral Res       Date:  2017-08-24       Impact factor: 5.970

2.  FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency.

Authors:  Huachao Huang; Netty Santoso; Derek Power; Sydney Simpson; Michael Dieringer; Hongyu Miao; Katerina Gurova; Chou-Zen Giam; Stephen J Elledge; Jian Zhu
Journal:  J Biol Chem       Date:  2015-09-16       Impact factor: 5.157

Review 3.  Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.

Authors:  Jean-François Gélinas; Deborah R Gill; Stephen C Hyde
Journal:  Microbiol Mol Biol Rev       Date:  2018-01-10       Impact factor: 11.056

4.  Genome-wide profiling identifies associations between lupus nephritis and differential methylation of genes regulating tissue hypoxia and type 1 interferon responses.

Authors:  Amanda Mok; Olivia Solomon; Renuka R Nayak; Patrick Coit; Hong L Quach; Joanne Nititham; Amr H Sawalha; Lisa F Barcellos; Lindsey A Criswell; Sharon A Chung
Journal:  Lupus Sci Med       Date:  2016-12-07

5.  Characterization of the Transcriptome and Gene Expression of Brain Tissue in Sevenband Grouper (Hyporthodus septemfasciatus) in Response to NNV Infection.

Authors:  Jong-Oh Kim; Jae-Ok Kim; Wi-Sik Kim; Myung-Joo Oh
Journal:  Genes (Basel)       Date:  2017-01-13       Impact factor: 4.096

6.  Identifying genome-wide immune gene variation underlying infectious disease in wildlife populations - a next generation sequencing approach in the gopher tortoise.

Authors:  Jean P Elbers; Mary B Brown; Sabrina S Taylor
Journal:  BMC Genomics       Date:  2018-01-19       Impact factor: 3.969

7.  Identification of HIV-1 Tat-Associated Proteins Contributing to HIV-1 Transcription and Latency.

Authors:  Maxime Junior Jean; Derek Power; Weili Kong; Huachao Huang; Netty Santoso; Jian Zhu
Journal:  Viruses       Date:  2017-04-01       Impact factor: 5.048

8.  Myeloid cell interferon responses correlate with clearance of SARS-CoV-2.

Authors:  Dhiraj Singh; Ekaterina Aladyeva; Shibali Das; Bindu Singh; Ekaterina Esaulova; Amanda Swain; Mushtaq Ahmed; Journey Cole; Chivonne Moodley; Smriti Mehra; Larry Schlesinger; Maxim Artyomov; Shabaana Khader; Deepak Kaushal
Journal:  Res Sq       Date:  2021-07-15

9.  The comprehensive immunomodulation of NeurimmiRs in haemocytes of oyster Crassostrea gigas after acetylcholine and norepinephrine stimulation.

Authors:  Hao Chen; Lingling Wang; Zhi Zhou; Zhanhui Hou; Zhaoqun Liu; Weilin Wang; Dahai Gao; Qiang Gao; Mengqiang Wang; Linsheng Song
Journal:  BMC Genomics       Date:  2015-11-14       Impact factor: 3.969

10.  Primate lentiviruses use at least three alternative strategies to suppress NF-κB-mediated immune activation.

Authors:  Dominik Hotter; Teresa Krabbe; Elisabeth Reith; Ali Gawanbacht; Nadia Rahm; Ahidjo Ayouba; Benoît Van Driessche; Carine Van Lint; Martine Peeters; Frank Kirchhoff; Daniel Sauter
Journal:  PLoS Pathog       Date:  2017-08-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.